Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.05%
SPX
+0.51%
IXIC
+1.02%
FTSE
+0.67%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Recently from Cashu

publisher logo
Cashu

Ionis Pharmaceuticals: Thriving Amid Market Volatility in Biopharmaceutical Innovation

10 days ago
publisher logo
Cashu

Ionis Pharmaceuticals' IONS Dawnzera Approved by FDA for Hereditary Angioedema Treatment

11 days ago
publisher logo
Cashu

Ionis Pharmaceuticals Gains FDA Approval for IONS Dawnzera, a New HAE Treatment

13 days ago

About

What does IONS do?
Ionis Pharmaceuticals, headquartered in Carlsbad, California, develops drugs using antisense technology and has five marketed medicines, including SPINRAZA and QALSODY, with a pipeline focused on neurology and cardiology. The company employs 927 people and has nine medicines in Phase III development.
Sector
💻 Health Care
IPO
CEO
Employees
1,069
Headquarters
California, USA
Website
http://www.ionispharma.com
Stocks
Health Care
ions
Ionis Pharmaceuticals
NASDAQ: IONS
+3.02 (+5.25%)
60.51
USD
At close at Sep 03, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials

Key Stats

Market Cap
9.15B
Dividend Yield
0.00%
P/E Ratio
-34.11
EPS
-3.04
Revenue
705.14M
Avg. Volume
5.17M